These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 32387339
1. Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide. Cristóbal-Luna JM, Correa-Basurto J, Mendoza-Figueroa HL, Chamorro-Cevallos G. Toxicol Appl Pharmacol; 2020 Jul 15; 399():115033. PubMed ID: 32387339 [Abstract] [Full Text] [Related]
2. Hepatotoxic Evaluation of N-(2-Hydroxyphenyl)-2-Propylpentanamide: A Novel Derivative of Valproic Acid for the Treatment of Cancer. Correa Basurto AM, Tamay Cach F, Jarillo Luna RA, Cabrera Pérez LC, Correa Basurto J, García Dolores F, Mendieta Wejebe JE. Molecules; 2023 Aug 28; 28(17):. PubMed ID: 37687111 [Abstract] [Full Text] [Related]
3. Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies. Mendieta-Wejebe JE, Silva-Trujillo A, Bello M, Mendoza-Figueroa HL, Galindo-Alvarez NL, Albores A, Tamay-Cach F, Rosales-Hernández MC, Romero-Castro A, Correa-Basurto J. J Pharm Pharmacol; 2020 Jul 28; 72(7):938-955. PubMed ID: 32307724 [Abstract] [Full Text] [Related]
4. N-(2'-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells. Sixto-López Y, Rosales-Hernández MC, Contis-Montes de Oca A, Fragoso-Morales LG, Mendieta-Wejebe JE, Correa-Basurto AM, Abarca-Rojano E, Correa-Basurto J. Int J Mol Sci; 2020 Aug 16; 21(16):. PubMed ID: 32824279 [Abstract] [Full Text] [Related]
7. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M. Birth Defects Res B Dev Reprod Toxicol; 2009 Oct 16; 86(5):394-401. PubMed ID: 19830722 [Abstract] [Full Text] [Related]
10. Apoptotic Effects of N-(2-Hydroxyphenyl)-2-Propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties. Castillo-Juárez P, Sanchez SC, Chávez-Blanco AD, Mendoza-Figueroa HL, Correa-Basurto J. Anticancer Agents Med Chem; 2021 Oct 16; 21(11):1451-1459. PubMed ID: 32723256 [Abstract] [Full Text] [Related]
13. Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid. Sedky AA, El Serafy OMH, Hassan OA, Abdel-Kawy HS, Hasanin AH, Raafat MH. Can J Physiol Pharmacol; 2017 Jun 16; 95(6):686-696. PubMed ID: 28177664 [Abstract] [Full Text] [Related]
14. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Borowicz KK, Luszczki JJ, Czuczwar SJ. Epilepsia; 2004 Oct 16; 45(10):1176-83. PubMed ID: 15461671 [Abstract] [Full Text] [Related]
19. Beneficial interaction between vigabatrin and valproate against seizures induced by pentylenetetrazole in mice. Cuadrado A, Armijo JA. Pharmacol Res; 2005 May 16; 51(5):489-96. PubMed ID: 15749465 [Abstract] [Full Text] [Related]
20. Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam. Kruse HJ, Kuch H. Arzneimittelforschung; 1985 May 16; 35(1):133-5. PubMed ID: 2859023 [Abstract] [Full Text] [Related] Page: [Next] [New Search]